Susquehanna International Group, LLP Repligen Corp Put Options Transaction History

Susquehanna International Group, LLP

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$119.79 - $167.35 $4.1 Million - $5.72 Million	34,200 Added 125.27%	61,500 $9.15 Million
Q2 2024 Aug 15, 2024	BUY	$120.0 - $182.95 $816,000 - $1.24 Million	6,800 Added 33.17%	27,300 $3.44 Million
Q1 2024 May 07, 2024	SELL	$170.78 - $208.42 $324,482 - $395,998	-1,900 Reduced 8.48%	20,500 $3.77 Million
Q4 2023 Feb 14, 2024	SELL	$114.17 - $185.35 $1.38 Million - $2.24 Million	-12,100 Reduced 35.07%	22,400 $4.03 Million
Q3 2023 Nov 14, 2023	SELL	$138.78 - $176.51 $5.5 Million - $6.99 Million	-39,600 Reduced 53.44%	34,500 $5.49 Million
Q2 2023 Aug 11, 2023	BUY	$138.42 - $180.31 $2.26 Million - $2.94 Million	16,300 Added 28.2%	74,100 $10.5 Million
Q1 2023 May 16, 2023	BUY	$154.26 - $198.1 $1.3 Million - $1.66 Million	8,400 Added 17.0%	57,800 $9.73 Million
Q4 2022 Feb 14, 2023	SELL	$162.42 - $220.56 $584,712 - $794,016	-3,600 Reduced 6.79%	49,400 $8.36 Million
Q3 2022 Nov 14, 2022	SELL	$160.42 - $256.21 $4.62 Million - $7.38 Million	-28,800 Reduced 35.21%	53,000 $9.92 Million

488

54.2M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.02B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.